Multi-Cancer Early Detection

Multi-cancer early detection (MCED) testing is a new approach to screening for cancer.


In pursuit of innovation to solve healthcare’s most important challenges

Grail is a healthcare company, pioneering new technologies to advance early cancer detection. They have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.

Cancer Screening Test

Easy to use, single blood test kit shipped directly to Participants. Adding a blood-based multi-cancer early detection test, along with recommended screenings,  can help screen for many of the deadliest cancers that don’t have recommended screening today.

Accurate Results

Grail's test kit can detect cancer signals with 99.5% specificity for over 50 types of cancers. It is able to predict the origin of the cancer while minimizing testing-associated potential risks, including overdiagnosis.

Early Detection is key 

Treating cancer starts with knowing you have it. Most cancers show no symptoms until later stages, when treatment options may be limited. When diagnosed early, before it has time to spread, the overall 5-year cancer-specific survival rate is 4x higher than when diagnosed late.

Intrested In Learning More?

Contact Level Care Health Consortium.


Please enter your name.
Please enter a subject.
Please enter a message.